NFE2L2 and astrocytoma (excluding glioblastoma): NRF2 is associated with cellular progression of brain cancers, such as astrocytomas, multiforme glioblastomas, gliosarcomas, medulloblastomas, and oligodendroglial and ependymal tumors [57].